Article
Oncology
Maria Cristina Leonardi, Chiara Fausta Cormio, Samuele Frassoni, Samantha Dicuonzo, Cristiana Fodor, Mattia Intra, Maria Alessia Zerella, Anna Morra, Federica Cattani, Stefania Comi, Nicola Fusco, Mattia Zaffaroni, Viviana Galimberti, Paolo Veronesi, Silvia Dellapasqua, Francesca De Lorenzi, Giovanni Battista Ivaldi, Vincenzo Bagnardi, Roberto Orecchia, Damaris Patricia Rojas, Barbara Alicja Jereczek-Fossa
Summary: The study evaluated the outcome of intraoperative electron boost and hypofractionated whole breast irradiation for breast cancer in young women. The treatment achieved excellent local control but resulted in tumor bed fibrosis.
RADIOTHERAPY AND ONCOLOGY
(2022)
Article
Multidisciplinary Sciences
Ting Yu, Yankang Li, Tao Sun, Min Xu, Wei Wang, Qian Shao, Yingjie Zhang, Jianbin Li, Jinming Yu
Summary: This study compared the dosimetric difference of hypofractionated whole-breast irradiation with sequential boost and simultaneous integrated boost in supine and prone positions, finding that prone SIB-HFWBI may be more suitable for postoperative radiotherapy in early-stage breast cancer patients.
SCIENTIFIC REPORTS
(2021)
Article
Oncology
Gerd Fastner, Roland Reitsamer, Christoph Gaisberger, Wolfgang Hitzl, Bartosz Urbanski, Dawid Murawa, Christiane Matuschek, Wilfried Budach, Antonella Ciabattoni, Juliann Reiland, Marie Molnar, Cristiana Vidali, Claudia Schumacher, Felix Sedlmayer
Summary: Intraoperative electron radiation therapy (IOERT) combined with moderate hypofractionation schedule has been shown to effectively reduce local recurrence rates in patients with invasive breast cancer after breast conserving surgery. The HIOB trial demonstrated low five-year local recurrence rates and minimal toxicity, making it a viable treatment option for these patients.
Article
Oncology
Luisa Schumacher, Joke Tio, Hans Theodor Eich, Gabriele Reinartz
Summary: This study compared the efficacy and toxicity of intraoperative radiotherapy (IORT) boost and intensity-modulated radiotherapy (IMRT) boost in breast cancer patients, finding no significant differences in overall survival, toxicity, and cosmetic outcomes between the two techniques, indicating their equivalence.
Review
Oncology
Camil Ciprian Mirestean, Roxana Irina Iancu, Dragos Petru Teodor Iancu
Summary: Breast cancer is a common cancer among women worldwide and is often treated with radiotherapy. By improving radiotherapy techniques and heart protection methods, the risk of cardiac toxicity from hypo-fractionated breast irradiation can be reduced.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Gabriela Oses, Tanny Daniela Barreto, Carla Cases, Diego Munoz-Guglielmetti, Gabriela Antelo, Meritxell Molla
Summary: This retrospective study compares hypofractionated boost and normofractionated boost in terms of skin toxicity and local control in breast cancer patients. The results show no significant differences between the two groups in terms of acute and chronic skin toxicity, as well as local control.
CLINICAL & TRANSLATIONAL ONCOLOGY
(2023)
Article
Oncology
Leonid B. Reshko, Jianmin Pan, Shesh N. Rai, Nicolas Ajkay, Anthony Dragun, Teresa L. Roberts, Elizabeth C. Riley, Amy R. Quillo, Charles R. Scoggins, Kelly M. McMasters, Harriet Eldredge-Hindy
Summary: The study found that postoperative WH-WBI has favorable disease-specific outcomes comparable to conventional and moderately hypofractionated radiation techniques for medically underserved patients with breast cancer, which can improve access to care for these patients.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(2022)
Article
Oncology
Riccardo Ray Colciago, Anna Cavallo, Maria Chiara Magri, Angelo Vitullo, Eliana La Rocca, Carlotta Giandini, Francesca Bonfantini, Serena Di Cosimo, Paolo Baili, Milena Sant, Emanuele Pignoli, Riccardo Valdagni, Laura Lozza, Maria Carmen De Santis
Summary: This study evaluated the impact of breast size on acute and late side effects in breast cancer patients undergoing hypofractionated radiotherapy. The results showed that breast volume and dose factors were associated with skin toxicity and fibrosis, while breast size did not directly affect the side effects. Recurrent association was found between acute and late toxicities and breast V105%, indicating the importance of a more homogenous RT technique for patients with larger breast size.
Article
Oncology
Raluca Stoian, Jan-Philipp Harald Exner, Mark Gainey, Thalia Erbes, Eleni Gkika, Ilinca Popp, Simon K. B. Spohn, David Krug, Ingolf Juhasz-Boess, Anca-Ligia Grosu, Tanja Sprave
Summary: This retrospective analysis compared the toxicity and oncological outcome of IORT and SIB as tumor bed boost after breast conserving surgery. The results showed that the two groups had similar local control and late toxicity, but the IORT group had a slight increase in acute toxicity.
FRONTIERS IN ONCOLOGY
(2023)
Article
Oncology
Nalee Kim, Jee Suk Chang, Chirag Shah, Hyejung Shin, Ki Chang Keum, Chang-Ok Suh, Yong Bae Kim
Summary: The study showed that for breast cancer patients undergoing adjuvant radiotherapy, HF-VMAT had significant advantages in reducing acute and late toxicities compared to CF-3D or HF-3D, especially in patients receiving regional node irradiation.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Oncology
Sofiane Allali, Matthieu Carton, Thomas Sarrade, Ophelie Querel, Alexandra Jacquet, Sofia Rivera, Youssef Ghannam, Karine Peignaux, Philippe Guilbert, Claire Chara-Brunaud, Julien Blanchecotte, David Pasquier, Severine Racadot, Celine Bourgier, Alain Labib, Julien Geffrelot, Ahmed Benyoucef, Francois Paris, Paul Cottu, Fabrice Andre, Youlia Kirova
Summary: Skin damage is a common and important toxicity during and after radiation therapy. This study found associations between skin erythema and obesity, type of surgery, axillary dissection, taxane-based chemotherapy, and the irradiation technique. Risk factors for fibrosis included age at diagnosis, obesity, tobacco, and the use of a boost. The use of IMRT technique decreased the occurrence of skin erythema.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Article
Oncology
Kunzhi Chen, Wuji Sun, Tao Han, Lei Yan, Minghui Sun, Wenming Xia, Libo Wang, Yinghua Shi, Chao Ge, Xu Yang, Yu Li, Huidong Wang
Summary: This study evaluated the robustness of five planning strategies in free-breathing breast hypofractionated radiotherapy with respect to positional variations. The results showed that IMRTePTV performed best at maintaining high target coverage with increasing isocenter shift, while IMRThybrid-flash would be adequate with positional uncertainty <5 mm.
FRONTIERS IN ONCOLOGY
(2023)
Article
Oncology
Mutlay Sayan, Zeinab Abou Yehia, Imraan Jan, Apar Gupta, Irina Vergalasova, Marc Reviello, Shicha Kumar, Bruce Haffty, Nisha Ohri
Summary: This study evaluated the changes in lumpectomy cavity volume during hypofractionated radiation and suggested the dosimetric benefits of adaptive boost planning in reducing normal tissue exposure in breast cancer patients.
ANTICANCER RESEARCH
(2022)
Article
Oncology
G. Oses, C. Cases, I. Valduvieco, B. Farrus, I. Alonso, X. Caparros, J. Mases, D. Munoz-Guglielmetti, A. Biete, C. Castro, E. Escudero, M. Molina, A. Herreros, J. Saez, M. Molla
Summary: This study assessed the long-term outcomes and chronic toxicity of IOERT boost in breast cancer treatment, showing that it is a safe option with low chronic toxicity. The recurrence rates are comparable to published data, highlighting the effectiveness of IOERT as a boost treatment in breast cancer.
CLINICAL & TRANSLATIONAL ONCOLOGY
(2021)
Article
Medicine, General & Internal
Zuleyha Akgun, Aydin Cakir, Esra Saglam, Sertac Demirel, Abdullah Igci, Serkan Keskin
Summary: This study aimed to evaluate the long-term adverse effects of hypofractionated radiotherapy on the physical appearance and overall well-being of breast cancer patients. The results showed that hypofractionated radiotherapy can be considered a viable treatment choice, even for patients with unfavorable conditions.
MEDICINA-LITHUANIA
(2023)
Article
Urology & Nephrology
Guido Barbagli, Francesco Montorsi, Sofia Balo, Salvatore Sansalone, Carla Loreto, Denis Butnaru, Vittorio Bini, Massimo Lazzeri
WORLD JOURNAL OF UROLOGY
(2019)
Article
Oncology
Cynthia Aristei, Valentina Lancellotta, Marco Piergentini, Giacomo Costantini, Simonetta Saldi, Sara Chierchini, Antonella Cavalli, Luca Di Renzo, Oscar Fiorucci, Massimo Guasticchi, Vittorio Bini, Alessandro Ricci
Article
Oncology
Valentina Lancellotta, Sara Chierchini, Elisabetta Perrucci, Simonetta Saldi, Lorenzo Falcinelli, Martina Iacco, Claudio Zucchetti, Isabella Palumbo, Vittorio Bini, Cynthia Aristei
CANCER INVESTIGATION
(2018)
Article
Dermatology
Maria Esposito, Francesca Prignano, Franco Rongioletti, Katharina Hansel, Leonardo Bianchi, Leonardo Pescitelli, Linda Lazzeri, Federica Ricceri, Cristina Mugheddu, Mauro Bavetta, Arianna Zangrilli, Luca Bianchi, Vittorio Bini, Luca Stingeni
JOURNAL OF DERMATOLOGICAL TREATMENT
(2019)
Editorial Material
Allergy
Luca Stingeni, Marta Tramontana, Leonardo Bianchi, Caterina Foti, Cataldo Patruno, Rosella Gallo, Monica Corazza, Donatella Schena, Nicola Milanesi, Fabrizio Guarneri, Vittorio Bini, Katharina Hansel
CONTACT DERMATITIS
(2019)
Editorial Material
Obstetrics & Gynecology
Elena Picchiassi, Giuliana Coata, Giulia Babucci, Irene Giardina, Valentina Summa, Federica Tarquini, Michela Centra, Vittorio Bini, Benito Cappuccini, Gian Carlo Di Renzo
OBSTETRICAL & GYNECOLOGICAL SURVEY
(2019)
Meeting Abstract
Oncology
S. Saldi, E. Perrucci, V. Lancellotta, I. Palumbo, L. Falcinelli, C. Mariucci, S. Chierchini, V. Bini, C. Aristei
RADIOTHERAPY AND ONCOLOGY
(2019)
Article
Urology & Nephrology
Paolo Casale, Alberto Saita, Massimo Lazzeri, Giovanni Lughezzani, Rodolfo Hurle, Vittorio Fa Sulo, Giulio M. Mondellini, Marco Paciotti, Luigi Domanico, Giuliana Lista, Davide Maffei, Marta Monari, Lucia Motta, Vittorio Bini, Ferruccio Ceriotti, Giorgio Guazzoni, Nicolo M. Buffi
MINERVA UROLOGICA E NEFROLOGICA
(2019)
Article
Medicine, General & Internal
Elena Bartoloni, Onelia Bistoni, Alessia Alunno, Lorenzo Cavagna, Linda Nalotto, Chiara Baldini, Roberta Priori, Colomba Fischetti, Micaela Fredi, Luca Quartuccio, Francesco Carubbi, Carlomaurizio Montecucco, Andrea Doria, Marta Mosca, Guido Valesini, Franco Franceschini, Salvatore De Vita, Roberto Giacomelli, Giulia Mirabelli, Vittorio Bini, Armando Gabrielli, Carlo Catassi, Roberto Gerli
JOURNAL OF CLINICAL MEDICINE
(2019)
Article
Obstetrics & Gynecology
Sandro Gerli, Federica Fraternale, Emanuela Lucarini, Sofia Chiaraluce, Alfonso Tortorella, Vittorio Bini, Irene Giardina, Patrizia Moretti, Alessandro Favilli
Summary: This study identified lower education level and previous postpartum depression as important risk factors for maternity blues development, while natural delivery was shown as a protective factor. These findings could contribute to the development of more accurate prevention programs post-delivery.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
(2021)
Article
Urology & Nephrology
Marilena Gubbiotti, Giulia Balboni, Vittorio Bini, Sandro Elisei, Chiara Bedetti, Moreno Marchiafava, Antonella Giannantoni
NEUROUROLOGY AND URODYNAMICS
(2019)
Article
Medicine, General & Internal
Elisa Reginato, Roberto Pippi, Cristina Aiello, Emilia Sbroma Tomaro, Claudia Ranucci, Livia Buratta, Vittorio Bini, Giulio Marchesini, Pierpaolo De Feo, Carmine Fanelli
JOURNAL OF CLINICAL MEDICINE
(2019)
Article
Pediatrics
Gabriele Mascherini, Cristian Petri, Piergiuseppe Cala, Vittorio Bini, Giorgio Galanti
Summary: This study investigated the lifestyle and body composition of young athletes, finding that overweight or obese individuals have more sedentary behaviors and consume less milk and yogurt compared to those with normal weight. While competitive sports often increase physical activity levels in young people, a comprehensive approach is necessary to establish a primary prevention strategy.
MINERVA PEDIATRICS
(2021)
Letter
Endocrinology & Metabolism
Francesca Cardini, Elisabetta Torlone, Vittorio Bini, Alberto Falorni